Improving In-hospital Stroke Service Utilisation in China
- Conditions
- Thrombolytic TherapyQuality ImprovementAcute StrokeDoor to Treatment Time
- Interventions
- Behavioral: Behaviour Change Wheel model guided intervention
- Registration Number
- NCT03317639
- Lead Sponsor
- Second Affiliated Hospital, School of Medicine, Zhejiang University
- Brief Summary
A cluster randomised controlled trial will be conducted, using hospital as randomisation unit. Hospitals in Zhejiang Province, China, will be randomised into two arms (1:1): an intervention arm and a control arm. Hospitals in the intervention arm will receive a multi-components intervention based on the Behaviour Change Wheel model, whereas hospitals in the control arm will receive no intervention and maintain existing care. The randomisation will be conducted after one-year baseline data collection. The following baseline data will be used for randomisation match: hospital classification, beds in stroke centre, thrombolysis patient number, and percentage of patients receiving thrombolysis within 60 minutes of stroke onset. Hospitals with no stroke centre or with \<20 cases received thrombolysis per year will be excluded from the study. The primary outcome will be difference between intervention arm and control arm in the percentage of patients receiving thrombolysis within 60 minutes of stroke onset on the follow-up stage (post-intervention).
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 1634
- AIS patients receiving IVT within 4.5 hours
- Patients who are not willing to attend this trial
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description an intervention arm Behaviour Change Wheel model guided intervention Hospitals in the intervention arm will receive a multi-components intervention based on the Behaviour Change Wheel model
- Primary Outcome Measures
Name Time Method Difference in the percentage of patients who Door-to-Needle Time≤60min Up to 24 hours Difference between intervention arm and control arm in the percentage of patients receiving thrombolysis within 60 minutes of stroke onset on the follow-up stage
- Secondary Outcome Measures
Name Time Method Onset-to-needle time Up to 24 hours The time between the symptom onset and the initiation of IVT
modified Rankin Scale score at discharge Up to 3 month modified Rankin Scale score at discharge, on which scores range from 0 (no neurologic deficit) to 6 (death)
Door-to-needle time Up to 24 hours The time between hospital arrival and the initiation of IVT
Death Up to 3 month Death at discharge
Symptomatic intracranial hemorrhage At 24 hours Intracranial hemorrhage at 24 hours associated with an increase of ≥4 points of NIHSS score from baseline, according to European Cooperative Acute Stroke Study (ECASS) II trial
Favorable neurological outcomes At 90 days Score of 0 to 1 on the modified Rankin Scale, on which scores range from 0 (no neurologic deficit) to 6 (death)
Trial Locations
- Locations (1)
The second affiliated hospital of Zhejiang University
🇨🇳Hangzhou, Zhejiang, China